HEALTHCARE · DIAGNOSTICS & RESEARCH

Natera Inc (NTRA) Stock Price, Analysis & Trade Signals

$281.30+6.91 (+2.52%)

Natera, Inc. is a diagnostics company focused on developing and commercializing a wide array of molecular testing services globally. Its portfolio includes several key offerings: Panorama, a non-invasive prenatal test (NIPT) that screens for chromosomal abnormalities in a fetus using a blood sample from the mother, and also determines zygosity in twin pregnancies. Vistara, designed to identify single-gene disorders by screening for specific single-gene mutations. Horizon, a comprehensive carrier screening test to determine an individual's carrier status for various genetic diseases. Spectrum, …

Market Cap
$27.68B
CEO
Steven Leonard Chapman
Employees
6,140
IPO Date
2015-07-01
Website
www.natera.com

Tabs · Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics